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Cell-mediated immunity: Dealing a direct blow to pathogens
Stefan H.E. Kaufmann
Cytotoxic T lymphocytes are essential for defence
against viral infections. Recent data demonstrating
direct killing of intracellular bacteria by granulysin, a
protein released from the granules of cytotoxic T
lymphocytes, emphasize the contribution of these
lymphocytes to the control of tuberculosis.
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With three million people dying of tuberculosis annually,
the World Health Organization has declared tuberculosis a
global emergency [1]. On the other hand, the same institu-
tion has estimated that two billion individuals have been
infected with the etiologic agent of this disease, Mycobact-
erium tuberculosis, the vast majority of whom will harbor the
pathogen without ever developing the disease. Thus, it
appears that M. tuberculosis lives in balanced coexistence
with the human host in most instances and only rarely
becomes detrimental. The immune system must therefore
be extremely efficacious in controlling M. tuberculosis and
is only overwhelmed after losing its full activity. 
M. tuberculosis is an intracellular bacterial pathogen that
preferentially resides within resting macrophages, bacte-
ria-engulfing cells of the immune system; once the
macrophages have been activated adequately, they
become the major effector cells in the immune response
against this pathogen. In mice, the cytokine interferon γ
(IFN-γ) produced by CD4+ T helper cells has been shown
to stimulate antimycobacterial activities in macrophages
which thus become endowed with the capacity to control
their intracellular predators. The major effector molecules
of activated macrophages in mice are the reactive nitrogen
intermediates, which kill bacteria by causing damage to
proteins and DNA. Although evidence to support a pro-
tective role of IFN-γ and reactive nitrogen intermediates
in human tuberculosis is increasing, these factors appear to
be less potent in man than in mice. Therefore, the ques-
tion arises as to whether other immune mechanisms are
required for efficient control of M. tuberculosis because this
pathogen is found in the two billion individuals that are
infected, yet are free of active disease. 
One candidate mechanism of protection could be afforded
by the second main function of T cells, namely cytotoxic
activity, typically exhibited by CD8+ T cells. These CD8+
cytotoxic T lymphocytes (CTLs) are central to the control
of viral infections. By lysing virus-infected host cells,
CTLs also reduce viral synthesis, thus promoting virus
elimination. At the same time, however, destruction of host
cells bears a certain risk for the host and this gains increas-
ing relevance the more valuable the affected cells are or
the more difficult it is to replace them. Two recent publi-
cations from Stenger et al. [2,3] emphasize a role for CTLs
in the control of human tuberculosis and have revealed
insights into the underlying molecular mechanism. 
Principally, CTLs can kill target cells via two major path-
ways. First, they express the death-inducing molecule Fas
ligand (FasL) on their cell surface and this molecule, upon
interaction with its receptor Fas on target cells, activates a
suicide pathway in the target cells. This killing mechanism
is not unique to CTLs; rather, it occurs frequently during
apoptosis, a form of programmed cell death. Second,
CTLs have unique cytoplasmic granules containing
various effector molecules with cytolytic activity, such as
perforin and granzymes. Once CTLs have come into close
contact with their target cells, they exocytose their granu-
lar content. Perforin is released and forms pores in the
target cell membrane, causing cellular swelling, rupture,
and eventually death. The perforin pores also open a port
for the entry of granzymes that are released from the gran-
ules and subsequently induce apoptosis in the target cells.
In this way, these two killer mechanisms synergize to
achieve target cell destruction in a most efficient way. 
In mice, CTLs that could lyse target cells infected with
intracellular bacteria, such as M. tuberculosis, were
described a decade ago [4]. It was also observed at that
time that the growth of M. tuberculosis was inhibited con-
comitantly with target cell killing. Even prior to this,
direct killing of bacterial and fungal pathogens by natural
killer (NK) cells — lymphoid cells with cytolytic activity
— had been described [4]. It was thus postulated that
CTLs, like cytokine-producing CD4+ T helper cells, are
involved in the immune response to microbial infections,
including tuberculosis (Figure 1) [4]. 
Although the possibility that target cell lysis could con-
tribute to pathogenesis had been considered, lysis was
assumed to have a more protective role: either CTLs
could directly affect intracellular pathogens or these lym-
phocytes could liberate the pathogens from protective
intracellular niches, thus promoting their killing by more
proficient phagocytes (Figure 1). Experiments using per-
forin-deficient mice have verified a protective role of
CTLs in vivo. These mice were hampered in their 
capacity to control infection of the model intracellular
pathogen Listeria monocytogenes [5]. To the contrary, it was
claimed that the perforin-deficient mice were not
impaired in their capacity to control M. tuberculosis infec-
tion [6,7]. The latter findings, however, may need to be
revisited because the recent paper by Stenger et al. [2]
mentions unpublished data from the same groups indicat-
ing exacerbation of tuberculosis in perforin-deficient mice
at late stages of disease.
The above studies were all performed in mice and, until
recently, the contribution of CD8+ T cells and of target cell
lysis to defence against tuberculosis in man remained
largely obscure. Firstly, mycobacteria-reactive CD8+ T cells
have been identified in tuberculosis patients [8]. Now,
Stenger et al. [3] not only show that human mycobacteria-
reactive CD8+ T cells express CTL activity, but also that
target cell lysis is accompanied by growth inhibition of
intracellular M. tuberculosis. Interestingly, CTLs that were
reactive to M. tuberculosis were not of the conventional
CD8+ T lymphocyte type that recognizes antigenic pep-
tides bound to major histocompatibility complex (MHC)
class I molecules. Rather, they were CD8+ T cells that rec-
ognized mycobacterial glycolipids presented by CD1 mole-
cules, which are related to MHC molecules. The
glycolipids are abundant components of the mycobacterial
cell wall, suggesting that CD1-restricted glycolipid-specific
T cells evolved to combat these major bacterial pathogens.
In the study by Stenger et al. [3], all of the CD8+ T cells
that inhibited M. tuberculosis growth contained the granular
killer machinery, but lacked cell-surface expression of
FasL. In contrast, CTLs that utilized FasL–Fas interac-
tions as their main mechanism of killing apparently did
not affect the growth of M. tuberculosis in target
macrophages [3]. 
In their more recent study, Stenger et al. [2] identified the
antimycobacterial effector molecule of CTLs as granulysin,
a previously identified component of cytotoxic granules in
CTLs and NK cells [2]. This molecule expresses potent
killer activity against many Gram-positive and Gram-nega-
tive bacteria and fungi, reducing their numbers by several
orders of magnitude in vitro. It also kills and inhibits the
growth of M. tuberculosis, though less potently than its
effects on the other bacteria and fungi. Mycobacteria are
extremely slow-growing with a doubling time of 8–12 hours
in vitro and they are remarkably resistant to various chemi-
cals and disinfectants, and numerous conventional antibi-
otics. To a large extent this is due to the waxy,
glycolipid-rich cell wall that probably also provides partial
resistance against granulysin. Although M. tuberculosis
organisms that resided in their natural habitat — the
macrophage — were fully protected against granulysin,
addition of perforin overcame this obstacle. Presumably the
pores formed by perforin in the macrophage membrane
promoted access of granulysin to the intracellular predators
(Figure 1). Together, these findings clearly point to gran-
ulysin and the granular killer machinery as the key weapon
R98 Current Biology, Vol 9 No 3
Figure 1
M. tuberculosis
M. tuberculosis
(with lesions)
TCR
CD8
Granulysin
Perforin
Antigenic ligand
MHC I / CD1
T cell
Macrophage
T cell
(a) Activation
T cell
T cell
(d) Dissemination
T cell
T cell
T cell
Current Biology   
(f) Granulysin-mediated killing(c) Tissue damage(b) Direct microbicidity
(e) Transmission
The different ways by which T cells could participate in the control of
bacterial infections. (a–e) The range of mechanisms of T-cell-mediated
death as proposed a decade ago [4]. (a) T cells activate antimicrobial
capacities in infected macrophages via the release of cytokines. 
(b) T-cell-mediated lysis of infected host cells directly affects microbial
growth. (c) Cytotoxic T cells can mediate tissue destruction. (d) Lysis
of infected host cells can promote microbial dissemination.
(e) Coordinate lysis and activation allows microbial transmission from a
cellular niche to a more aggressive effector cell. Solid arrows represent
lysis; open arrows, activation; and dotted arrows, cytokines. (f) Recent
findings of Stenger et al. [2,3] provide a molecular explanation for the
mechanism outlined in (b). Granules of CTLs contain, amongst other
cytolytic molecules, perforin and granulysin. Perforin creates
membrane pores in infected host cells so that granulysin can reach
intracellular microbes and kill them.
of CTLs in their fight against M. tuberculosis and argue
against the participation of apoptosis. 
In contrast, a recent study advocated apoptosis as the rele-
vant mechanism of M. tuberculosis growth inhibition and
killing by CTLs [9]. In these experiments, induction of
apoptosis in macrophages infected with M. tuberculosis
inhibited the growth of the pathogens to the same degree
as observed in the studies by Stenger et al. [3]. It is most
likely that there are a range of mechanisms of myco-
bacterial inhibition by CTLs. For example, it was shown
previously that exogenous ATP causes death both of
macrophages and of intracellular M. bovis Bacille Camille
Guerin (BCG) [10], a microbe that can be used as a model
pathogen in such studies as well as being more commonly
used as an anti-tuberculosis vaccine. Mycobacterial growth
inhibition is induced by binding of exogenous ATP to spe-
cific cell surface receptors on macrophages, and ATP is
released by CTLs upon target cell interaction. Hence, it
appears that, depending on the conditions, various CTL
activities have the potential to inhibit the growth of intra-
cellular M. tuberculosis. Time will reveal whether all of these
mechanisms are equally important, whether a hierarchy
exists, or whether the mechanisms synergize to achieve
maximum effects.
M. tuberculosis, as well as many other bacterial pathogens,
poses increasing problems globally due to the emergence
of multidrug-resistant strains against which classical
chemotherapies are no longer effective [1]. The need for
conceptually novel anti-infective agents is therefore
obvious. Antibiotics are generally developed from 
substances that are produced by microbes to provide
themselves with a survival advantage over other micro-
organisms. In contrast, granulysin represents an effector
molecule of the mammalian immune system. It would be
rewarding if we could learn from our own defence strate-
gies how to design new anti-infective agents for the fight
against major scourges such as tuberculosis.
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